Form 4 for CELU Celularity Inc
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-17 · accession 0001493152-25-007596 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-17 | CELU | Haines John R | Senior Exec VP | F - Tax | $2.14 | -7,035 | 28.1K | -20% | -$15.1K |
| D | 2025-02-19 | 2025-02-17 | CELU | Haines John R | Senior Exec VP | M - OptEx | $0.00 | +20.0K | 35.1K | +133% | $0 |
| D | 2025-02-19 | 2025-02-17 | CELU | Haines John R | Senior Exec VP | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-17 | F | D | 7,035 | $2.14 | 28,057 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-02-17 | M | A | 20,000 | $0.00 | 35,092 | D | — | — | (F1) Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On February 17, 2023, the reporting person was granted 20,000 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22, 2023. |
| 3 | Derivative | Restricted Stock Units | 2025-02-17 | M | D | 20,000 | $0.00 | 0 | D | — · — to — | 20,000 Class A Common Stock | (F3) Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. (F4) On February 17, 2023, the reporting person was granted 20,000 RSUs, which vested on February 17, 2025. The Class a common stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4. |